日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Constitutive EGFR Activation Induced by PTPRR Downregulation Confers Resistance to KRAS Inhibitors

PTPRR下调诱导的组成型EGFR激活赋予KRAS抑制剂耐药性

Kanemura, Hiroaki; Takehara, Toshiyuki; Maenishi, Osamu; Tomida, Shuta; Iwawaki, Natsumi; Kunimasa, Kei; Nakayama, Tomohiro; Watanabe, Satomi; Suzuki, Shinichiro; Sakai, Kazuko; Azuma, Koichi; Kudo, Keita; Nishio, Kazuto; Nakagawa, Kazuhiko; Hayashi, Hidetoshi; Teramura, Takeshi; Yonesaka, Kimio

Serum VEGF-A as a biomarker for the addition of bevacizumab to chemo-immunotherapy in metastatic NSCLC

血清 VEGF-A 作为转移性非小细胞肺癌化疗联合免疫治疗中加用贝伐单抗的生物标志物

Tanaka, Kentaro; Sugisaka, Jun; Shiraishi, Yoshimasa; Watanabe, Yasutaka; Daga, Haruko; Azuma, Koichi; Nishino, Kazumi; Mori, Masahide; Ota, Takayo; Saito, Haruhiro; Hata, Akito; Sakaguchi, Tadashi; Kozuki, Toshiyuki; Akamatsu, Hiroaki; Matsumoto, Hirotaka; Tachihara, Motoko; Wakuda, Kazushige; Sato, Yuki; Ozaki, Tomohiro; Tsuchiya-Kawano, Yuko; Yamamoto, Nobuyuki; Nakagawa, Kazuhiko; Okamoto, Isamu

Randomized Phase III Study of EGFR Tyrosine Kinase Inhibitor and Intercalated Platinum-Doublet Chemotherapy for Non-Small Cell Lung Cancer Harboring EGFR Mutation

EGFR酪氨酸激酶抑制剂联合铂类双药化疗治疗携带EGFR突变的非小细胞肺癌的随机III期研究

Kanda, Shintaro; Niho, Seiji; Kurata, Takayasu; Nomura, Shogo; Kawashima, Yosuke; Iwama, Eiji; Yokoyama, Toshihide; Watanabe, Yasutaka; Tanaka, Hiroshi; Fujiwara, Yutaka; Zenke, Yoshitaka; Azuma, Koichi; Taniguchi, Hirokazu; Toyozawa, Ryo; Hosomi, Yukio; Murakami, Haruyasu; Hara, Satoshi; Bessho, Akihiro; Yamamoto, Nobuyuki; Ohe, Yuichiro

Machine learning-based insights into circulating autoantibody dynamics and treatment outcomes in patients with NSCLC receiving immune checkpoint inhibitors

基于机器学习的对接受免疫检查点抑制剂治疗的非小细胞肺癌患者循环自身抗体动态和治疗结果的深入分析

Wei, Feifei; Takeda, Hiroyuki; Azuma, Koichi; Nakahara, Yoshiro; Igarashi, Yuka; Murotani, Kenta; Saito, Haruhiro; Murakami, Shuji; Kondo, Tetsuro; Kouro, Taku; Himuro, Hidetomo; Tsuji, Kayoko; Komahashi, Mitsuru; Sawasaki, Tatsuya; Sasada, Tetsuro

Durvalumab Post Concurrent Chemoradiotherapy in Japanese Patients With Limited-Stage Small-Cell Lung Cancer in the Phase 3 ADRIATIC Trial

在 ADRIATIC 3 期试验中,度伐利尤单抗用于治疗日本局限期小细胞肺癌患者的同步放化疗后治疗

Zenke, Yoshitaka; Shiraishi, Yoshimasa; Goto, Yasushi; Azuma, Koichi; Okishio, Kyoichi; Ogino, Hirokazu; Horio, Yoshitsugu; Oizumi, Satoshi; Hayama, Manabu; Nii, Masahiro; Harada, Masaya; Mann, Helen; Olivo, Yuka S; Jiang, Haiyi; Senan, Suresh

Association between soluble immune mediators and outcomes in patients with unresectable stage III non-small cell lung cancer treated with concurrent chemoradiotherapy followed by durvalumab

可溶性免疫介质与接受同步放化疗后序贯度伐利尤单抗治疗的不可切除的III期非小细胞肺癌患者预后之间的关联

Tokito, Takaaki; Azuma, Koichi; Murotani, Kenta; Matsuo, Norikazu; Matama, Goushi; Murata, Daiki; Sasada, Tetsuro; Hoshino, Tomoaki

Pembrolizumab and Pemetrexed for Older Patients With Nonsquamous NSCLC and Programmed Cell Death-Ligand 1 Tumor Proportion Scores of Less Than 50

帕博利珠单抗联合培美曲塞用于治疗老年非鳞状非小细胞肺癌患者,且程序性死亡配体1(PD-L1)肿瘤比例评分低于50。

Kogure, Yoshihito; Hashimoto, Hiroya; Daga, Haruko; Fukuda, Yasushi; Bessho, Akihiro; Yamada, Tadaaki; Toi, Yukihiro; Kimura, Tomoki; Yoshioka, Hiroshige; Azuma, Koichi; Furuya, Naoki; Fukui, Yasutaka; Saito, Akiko M; Yamamoto, Nobuyuki; Saka, Hideo; Kondo, Masashi

Turtle Study: A Phase 2 Study of Durvalumab Plus Carboplatin and Etoposide in Elderly Patients With Extensive-Stage SCLC (LOGiK 2003)

Turtle 研究:一项针对老年广泛期小细胞肺癌患者的 Durvalumab 联合卡铂和依托泊苷的 II 期研究 (LOGiK 2003)

Ishii, Hidenobu; Azuma, Koichi; Yamanaka, Yuta; Yoshioka, Hiroshige; Toi, Yukihiro; Shingu, Naoki; Naoki, Katsuhiko; Okamoto, Masaki; Tsuchiya-Kawano, Yuko; Harada, Taishi; Inoue, Hiroyuki; Ishii, Hiroshi; Tobino, Kazunori; Nakashima, Chiho; Koreeda, Yoshifusa; Hisamatsu, Yasushi; Tsumura, Shinsuke; Inagaki, Takashi; Mizuno, Keiko; Shimose, Takayuki; Okamoto, Isamu

Five-Year Effectiveness and Renal Safety Following Switching to Tenofovir Alafenamide in Chronic Hepatitis B Patients With Renal Impairment

慢性乙型肝炎合并肾功能不全患者改用替诺福韦艾拉酚胺治疗五年后的疗效和肾脏安全性

Ogawa, Eiichi; Kohjima, Motoyuki; Koyanagi, Toshimasa; Dohmen, Kazufumi; Ooho, Aritsune; Kawano, Akira; Furusyo, Norihiro; Kajiwara, Eiji; Satoh, Takeaki; Takahashi, Kazuhiro; Azuma, Koichi; Sugimoto, Rie; Ichiki, Yasunori; Senju, Takeshi; Amagase, Hiromasa; Tanaka, Masatake; Nakamuta, Makoto; Nomura, Hideyuki; Hayashi, Jun

Biomarker study on pneumonitis in durvalumab maintenance therapy after chemoradiotherapy for stage III non-small cell lung cancer

针对接受放化疗后接受度伐利尤单抗维持治疗的III期非小细胞肺癌患者的肺炎生物标志物研究

Yano, Ryo; Tokito, Takaaki; Murotani, Kenta; Murata, Daiki; Tsuneyoshi, Shingo; Ishii, Hidenobu; Azuma, Koichi; Hoshino, Tomoaki